Slovak
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Strana 1 od 20 výsledky
Letter: Levodopa and L-arginine to test GH release in obesity.
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Letter: Levodopa as a treatment of obesity.
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
[Effect of long-term fasting on the blood serum insulin and growth hormone levels after loading tests with glucose, levodopa and exertion in obese patients with mormal and abnormal carbohydrate tolerance].
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Pre-operative obesity may influence subthalamic stimulation outcome in Parkinson's disease.
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
BACKGROUND
Pre-operative predictive factors for optimal post-operative effect of subthalamic nucleus (STN) stimulation in Parkinson's disease (PD) have been previously reported. No study has explicitly assessed the link between excess pre-operative body weight and STN stimulation outcome.
METHODS
We
An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay.
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
OBJECTIVE
To describe a probable interaction between enteral feeds and levodopa leading to neuroleptic malignant-like syndrome (NMLS) in a polytrauma patient with Parkinson's disease (PD).
METHODS
A 63-year-old morbidly obese male polytrauma patient with PD and type 2 diabetes mellitus was admitted
The sleeve gastrectomy intervention to treat morbid obesity in a Parkinson's disease patient.
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
OBJECTIVE
Some Parkinson's disease patients may develop morbid obesity, on account of the reduction in exercise and/or of the appearance of compulsive food intake in the first years after diagnosis. The prescription of central appetite suppressants is actually not recommended in Parkinson's disease
The effect of levodopa with carbidopa (Sinemet R) on the metabolic response to semistarvation.
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
It has been reported that levodopa will prevent the adaptive fall in the resting metabolic rate (RMR) on a weight-reducing diet. Whether levodopa has a central or peripheral effect on the RMR has been investigated by giving carbidopa, a peripheral dopa decorboxylase inhibitor with levodopa (as
Reduced Growth Hormone Secretion is Associated with Nonalcoholic Fatty Liver Disease in Obese Children.
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
The purpose of the study was to evaluate the relationship between arginine-levodopa-induced growth hormone (GH) secretion and nonalcoholic fatty liver disease (NAFLD) in obese children. This study includes a total of 84 obese and 43 normal weight children. The obese subjects are divided into two
Effect of catecholamine replacement with levodopa on the metabolic response to semistarvation.
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
The resting metabolic rate (R.M.R.) falls on energy restriction in association with a fall in the circulating calorigenic hormones, triiodothyronine (T3) and noradrenaline. Levodopa, a precursor of catecholamines, was given to obese subjects receiving a low-energy diet in an attempt to prevent the
Reduced peak stimulated growth hormone is associated with hyperuricemia in obese children and adolescents.
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
The purpose of the study is to investigate whether reduced peak GH response to arginine-levodopa test is associated with hyperuricemia in obese children and adolescents. The study population consisted of a total sample of 78 obese and 30 normal-weight children and adolescents without known
Modulation of nutritional state in Parkinsonian patients with bilateral subthalamic nucleus stimulation.
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Chronic bilateral subthalamic stimulation (DBS-STN) provides considerable clinical benefits in Parkinson disease patients, with improvement in primary symptoms and resolution of side effects of chronic pharmacological treatment. Apart from its therapeutic effects on PD symptoms, DBS-STN also appears
Vascular risk factors and depression in Parkinson's disease.
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
The aim of this study was to address the vascular depression hypothesis in Parkinson's disease (PD) from a large cohort of Chinese population.
A cross-sectional analysis of 1784 Chinese patients with PD was conducted. Patients were divided into absence of depression (score ≤ 20) and presence of
Hypothalamic atrophy.
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
A patient, who has been followed for thirteen years, developed the first symptoms of progressive hypothalamic atrophy at the age of 39. The diagnosis was confirmed by pneumoencephalography five years after onset. Hypothalamic dysfunction was manifested clinically by loss of libido, impotence,
Orexigenic effects of omentin-1 related to decreased CART and CRH gene expression and increased norepinephrine synthesis and release in the hypothalamus.
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Omentin-1, a visceral fat depot-specific secretory protein, is inversely correlated with obesity and insulin resistance. We investigated, in rats, the effects of chronic omentin-1 administration (8 μg/kg, intraperitoneally, once daily for 14-days) on feeding behavior and related hypothalamic
Shedding light on thyroid hormone disorders and Parkinson disease pathology: mechanisms and risk factors
Články môžu prekladať iba registrovaní používatelia
Prihlásiť Registrácia
Parkinson's disease (PD) is a neurodegenerative disorder characterized by loss of dopaminergic neurons. Dopaminergic system is interconnected with the hypothalamic-pituitary-thyroid axis. Dopamine (DA) upregulates thyrotropin releasing hormone (TRH) while downregulating thyroid stimulating hormone
Najkompletnejšia databáza liečivých bylín podporovaná vedou
- Pracuje v 55 jazykoch
- Bylinné lieky podporené vedou
- Rozpoznávanie bylín podľa obrázka
- Interaktívna GPS mapa - označte byliny na mieste (už čoskoro)
- Prečítajte si vedecké publikácie týkajúce sa vášho hľadania
- Vyhľadajte liečivé byliny podľa ich účinkov
- Usporiadajte svoje záujmy a držte krok s novinkami, klinickými skúškami a patentmi
Zadajte príznak alebo chorobu a prečítajte si o bylinách, ktoré by vám mohli pomôcť, napíšte bylinu a pozrite sa na choroby a príznaky, proti ktorým sa používa.
* Všetky informácie sú založené na publikovanom vedeckom výskume
